AIN457F
Biological
Novartis Pharma AG
Total Payments
$327,900
Transactions
114
Doctors
15
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $213,052 | 95 | 9 |
| 2017 | $114,847 | 19 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $157,002 | 15 | 47.9% |
| Consulting Fee | $115,671 | 22 | 35.3% |
| Travel and Lodging | $53,653 | 58 | 16.4% |
| Food and Beverage | $1,575 | 19 | 0.5% |
Payments by Type
General
$170,898
99 transactions
Research
$157,002
15 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CAIN457F2304 | Novartis Pharma AG | $157,002 | 0 |
Top Doctors Receiving Payments for AIN457F
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cincinnati, OH | $157,002 | 15 |
| , MD | Rheumatology | Portland, OR | $45,762 | 21 |
| , MD | Rheumatology | Seattle, WA | $41,124 | 17 |
| , M.D | Rheumatology | San Francisco, CA | $26,602 | 13 |
| , M.D., PH.D | Diagnostic Radiology | Kentfield, CA | $12,142 | 8 |
| , M.D | Ophthalmology | Portland, OR | $10,731 | 12 |
| , MD, PHD | Dermatology | New York, NY | $9,652 | 2 |
| , M.D | Allergy & Immunology | La Jolla, CA | $9,319 | 6 |
| , MD | Rheumatology | Duncansville, PA | $7,928 | 6 |
| , MD | Dermatology | New York, NY | $3,602 | 1 |
| , MD | Pediatric Rheumatology | Cincinnati, OH | $978.75 | 1 |
| , M.D | Rheumatology | Portola Valley, CA | $973.50 | 1 |
| , M.D | Rheumatology | Dallas, TX | $818.45 | 4 |
| , M.D | Pediatric Rheumatology | Cincinnati, OH | $543.75 | 1 |
| , MD | Rheumatology | Los Angeles, CA | $361.45 | 3 |
| , M.D | Rheumatology | Wheaton, MD | $361.45 | 3 |
Ad
Manufacturing Companies
- Novartis Pharma AG $327,900
Product Information
- Type Biological
- Total Payments $327,900
- Total Doctors 15
- Transactions 114
About AIN457F
AIN457F is a biological associated with $327,900 in payments to 15 healthcare providers, recorded across 114 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $213,052 was paid across 95 transactions to 9 doctors.
The most common payment nature for AIN457F is "Unspecified" ($157,002, 47.9% of total).
AIN457F is associated with 1 research study, including "CAIN457F2304" ($157,002).